A case series showed that chimeric antigen receptor T-cell therapy targeting CD19 halted the progression of fibrotic organ ...

A research team led by Prof. Wang Haoyi from the Institute of Zoology (IOZ) of the Chinese Academy of Sciences has developed ...

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) is one of several contenders to a heretofore unclaimed crown: engineered cell ...

Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion–Positive Solid Tumors (Children's Oncology Group ADVL1823) Sixteen patients were treated, with a median of four ...

New research has suggested that a simple and 'relatively cheap' supplement or diet could be the key to improving cancer ...

Immunotherapies have shaped the cancer research space over the past decade, proving effective for the treatment of some ...

Data from the Phase I/II TRANSCEND CLL 004 study evaluating the combination of Bristol Myers Squibb’s (BMS’s) Breyanzi ...

Adoptive cell transfer with chimeric antigen receptor (CAR)-expressing T cells can induce remarkable complete responses in ...

Research shows that GBM organoids are a powerful, accurate tool for understanding what happens when treating a brain tumor ...

This early data has demonstrated a clear improvement in GLPG5101 efficacy over its competitors in iNHL and MCL.

The study reveals IL-15's role in enhancing GPC3 CAR T cell therapy, improving tumor targeting and T cell survival in ...

For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), obecabtagene autoleucel (obe-cel), an ...